Vitamin D is produced in the skin, under the influence of UVB sunlight converting 7-dehydrocholesterol to pre-vitamin D3, with lesser quantities also found in the diet in the form of both vitamin D2 (ergocalciferol) and vitamin D3 (cholecalciferol). In the dermis, pre-vitamin D3 is rapidly converted to vitamin D3, prior to its subsequent conversion to 25-hydroxyvitamin D (25(OH)D) in the liver. Further hydroxylation of 25(OH)D to the active form of vitamin D, 1,25-dihydroxyvitamin D (1,25(OH)2D), occurs in the kidneys(Reference Holick1). 1,25(OH)2D is a hormone essential for Ca homeostasis and bone mineralization but is increasingly being recognized as having effects on various organs(Reference Holick2), with 1,25(OH)2D receptors found in the nucleus of most tissues(Reference Malloy, Pike and Feldman3). In addition to its role in Ca homeostasis, vitamin D has also been implicated in osteoporotic fractures, bowel cancer, arthritis, diabetes and CVD(Reference Holick1, Reference Holick2, Reference Lappe, Travers-Gastafson and Davies4–Reference Garland, Garland and Gorham12).
While the definition of both vitamin D deficiency and appropriate supplementation levels continues to be hotly debated(Reference Malabanan, Veronikis and Holick13), it is generally accepted that serum 25(OH)D concentrations of 20–30 ng/ml represent insufficiency, concentrations below 20 ng/ml deficiency, and concentrations below 10 ng/ml severe deficiency(Reference Holick1). Deficiency of vitamin D is now recognized as endemic in many regions of the world including North America, Europe and the Middle East(Reference Binkley, Novotny and Krueger14–Reference Rockell, Green and Skeaff20). With the most common cause of vitamin D deficiency being inadequate sunlight exposure, it is not surprising that countries at higher latitude have high incidence of deficiency(Reference Andersen, Molgaard and Skovgaard18). However, more recently, inner-city young adults in America have been found to be deficient in vitamin D(Reference Gordon, DePeter and Feldman16, Reference Lovell21). Despite high sunlight hours, vitamin D deficiency is well described in women in the Middle East, primarily as a result of cultural norms of keeping skin covered(Reference Allali, El Aichaoui and Saoud22, Reference Fonseca, Tongia and El-Hazmi23).
With the majority of vitamin D studies in the Middle East focusing on women(Reference Hashemipour, Larijani and Adibi15, Reference Allali, El Aichaoui and Saoud22–Reference Hatun, Islam and Cizmecioglu24), young men appear to be an under-recognized at-risk group(Reference Hashemipour, Larijani and Adibi15, Reference Siam, Hammoudeh and Bener25). Indeed, in the 1980s, 73 % of young Saudi Arabian men were found to have 25(OH)D levels less than 10 ng/ml(Reference Sedrani, Wahab and Elidrissy26). Despite this evidence, it has been anticipated that as a result of high sunshine hours, vitamin D levels in young male athletes would be within normal limits, especially those who regularly participate in outdoor sports. However, athletes are not immune to vitamin D deficiency and concern has recently been raised about the vitamin D status of athletes(Reference Willis, Peterson and Larson-Meyer27): both elite female Australian gymnasts and Finnish female athletes were recently found to be deficient in 25(OH)D(Reference Lovell21, Reference Lehtonen-Veromaa, Mottonen and Irjala28). Furthermore, while little is known of any performance impact of 25(OH)D deficiency, some authors suspect it may be a marked impediment when not available in adequate doses(Reference Cannell, Hollis and Sorenson29). Indeed, despite limited scientific evidence at the time, in the early part of the 20th century athletes were allegedly using UVB rays as an ergogenic aid(Reference Allen and Cureton30, Reference Hoberman31) and recently authors have proposed that 25(OH)D deficiency may in fact impact upon exercise performance in young women(Reference Ward, Das and Berry32, Reference El-Hajj, Nabulsi and Tamim33). For example, in a recent study of ninety-nine postmenarchal adolescent girls in England, Ward et al.(Reference Ward, Das and Berry32) found a positive relationship between serum 25(OH)D level and jump height, jump velocity and power. In addition to any immediate performance deficits for athletes, 25(OH)D deficiency may have both immediate effects on health such as stress fractures, as well as substantial long-term health impacts(Reference Lappe, Travers-Gastafson and Davies4, Reference Ruohola, Laaksi and Ylikomi34, Reference Lappe, Cullen and Haynatzki35). Subsequently the identification and correction of any deficiency is of paramount importance.
In the present study we aimed to evaluate the 25(OH)D status and risk factors for 25(OH)D deficiency in young male Middle Eastern athletes.
Methodology
Participants and procedure
Ethical approval for the study was obtained from the Qatar Orthopaedic and Sports Medicine Hospital ethics committee, and all athletes completed an informed consent to participate. All athletes who attended the Qatar Orthopaedic and Sports Medicine Hospital for a pre-participation medical evaluation between 9 April and 16 October 2008 undertook a blood test to evaluate their vitamin D status. This included the assessment of serum 25(OH)D, serum 1,25(OH)2D, plasma parathyroid hormone (PTH), total Ca, phosphate and alkaline phosphatase (ALP). In addition, with the assistance of a nurse, subjects completed a vitamin D questionnaire. Athletes in this sample ranged from professional or semi-professional to amateur and junior sports participants in sports including football, athletics, handball, shooting, squash, cycling, martial arts and body-building. In addition, football referees were included in this sample as they train and participate in a similar manner to football participants in Qatar. Screened athletes were excluded from the study if female, if they declined consent to participate in the study, were not of Middle Eastern birth place or did not complete key components (i.e. questionnaire) of the vitamin D screening process within the prescribed study period.
Of a total sample size of 449 athletes who were screened between April and October, ninety-three Middle Eastern sportsmen completed all requirements and were eligible for the study (age 21·3 (sd 6·9) years; range 13–45 years). Country of origin included Qatar (n 81), Iraq (n 4), Oman (n 3), Iran (n 2) and one each from Bahrain, Jordan and Syria. A smaller subset (thirty-nine athletes) also underwent a bone density assessment.
Questionnaire
The questionnaire addressed specific areas relevant to exercise and vitamin D risk analysis. This included: training and competition (indoors and outdoors percentage); skin exposure (nil, hands and face only, more than hands and face); daily sunlight exposure in last month (nil or <30 min, 30–60 min, 60–120 min, >120 min); sunscreen use (yes, no); previous history of stress fracture, fracture, gastrointestinal problems, smoking, alcohol (yes, no); family history of osteoporosis, fractures or diabetes (yes, no); supplements and medication use; nurse assessment of skin colour (dark, olive, fair).
Laboratory analyses
A portion of each blood sample was separated for immediate analysis (Ca, Mg, phosphate, ALP). Total Ca was measured using a modified calcium o-cresolphthalein complexone reaction, Mg by a modified methylthymol blue complexometric procedure and phosphate by a modified phosphomolybdolate method (Dimension®; Dade Behring, Eschborn, Germany).
The remainder of the blood sample was then separated into two aliquots of serum for analysis of 25(OH)D and 1,25(OH)2D and one aliquot of plasma for PTH assessment. Samples for PTH and 1,25(OH)2D were transported at −20°C, and 25(OH)D at 4°C, as per laboratory guidelines.
25(OH)D and PTH were analysed utilizing chemiluminescent immunoassay technology (Liaison® 25-OH Vitamin D Total Assay; Diasorin Inc., Saluggia (Vercelli), Italy). Sensitivity for 25(OH)D was 7 ng/ml, below which levels were recorded as <7 ng/ml. The intra- and inter-assay CV was 7·6–9·4 % and 9·8–13·4 %, respectively.
Bone mineral density
Dual-energy X-ray absorptiometry (DEXA; Osteocore III, Perols, France, version 5.22b) scanning was used to assess hip and spine bone mineral density (BMD) in thirty-nine of the screened sportsmen. The complete sample could not be assessed in the study period owing to accessibility issues to the DEXA machine, and athletes were imaged based on their availability during this period. Those athletes who completed DEXA scanning did not differ from the complete study group, other than having a significantly higher incidence of a family history of osteoporosis and fatigue fractures in elderly relatives. A certified technologist from the International Society of Clinical Densitometry performed all calibrations and measurements. The DEXA machine was calibrated each morning before the test. The CV for these records is <1·01 % in our laboratory. BMD was calculated in g/cm2 for spine (L2–L4), hip-neck and hip-total. In addition, the clinical age-matched and gender-specific Z-score index was used to classify the BMD.
Statistical analysis
The relationships between the continuous variables were assessed by correlation and linear regression analysis. The relationships between the categorical variables were assessed by χ 2 statistics. The relationship between a continuous and a categorical variable was assessed by one-way ANOVA. All continuous variables presented a normal distribution with a skewness index below 1. Data are presented as mean and standard deviation. A P value of <0·05 was considered statistically significant. Given the extremely low values of 25(OH)D, results were divided into clinically relevant groups (<10 ng/ml, 10–<20 ng/ml, 20–<30 ng/ml) for further evaluation.
Results
Athlete characteristics
As illustrated in Fig. 1, fifty-four (58 %) athletes had levels of 25(OH)D less than 10 ng/ml (mean age 20·41 (sd 7·05) years, mean BMI 22·59 (sd 3·58) kg/m2), with a further thirty-one (33 %) having serum 25(OH)D less than 20 ng/ml (mean age 21·29 (sd 6·54) years, mean BMI 22·13 (sd 4·58) kg/m2). All remaining athletes had serum 25(OH)D less than 30 ng/ml (mean age 26·88 (sd 5·49) years, mean BMI 24·93 (sd 2·41) kg/m2). No athlete described supplementing with oral vitamin D, although three athletes (3 %) used multivitamins which on investigation were found to contain vitamin D, and thirty-two (34 %) utilized multivitamins for which the vitamin D content could not be confirmed. Eleven (12 %) athletes supplemented with Ca. Only six (7 %) athletes used sunscreen despite seventy-three (79 %) reportedly training outdoors 100 % of the time. Despite most of the athletes reportedly completing all of their training outdoors, a third (n 31; 33 %) of athletes still described less than 30 min of daily sunlight exposure (total daily sunlight exposure: 30–60 min, n 24 (26 %); 60–120 min: n 21 (23 %); >120 min, n 16 (17 %)). The majority of athletes only exposed their hands and face, or less, to the sun on a regular basis (Table 1).
Serum levels of 25-hydroxyvitamin D (25(OH)D) among ninety-three Middle Eastern male athletes presenting to hospital for an annual screening, Doha, Qatar, April–October 2008
Serum levels of 25-hydroxyvitamin D (25(OH)D) as a function of reported skin exposure to sunlight among ninety-three Middle Eastern male athletes presenting to hospital for an annual screening, Doha, Qatar, April–October 2008
Serum 25(OH)D was not dependent on the reported skin exposure (χ 2 = 0·43, NS).
No athletes reported a history of stress fracture, but fourteen (15 %) athletes indicated a history of sixteen traumatic fractures including nine upper limb, five lower limb and one facial fracture. Seven (8 %) reported a family history of osteoporosis and fatigue fractures in elderly relatives. Fifty-one (55 %) athletes described a family history of diabetes, although the degree of relative and the type of diabetes are unclear. Skin colour was assessed as dark (21 %), olive (61 %) or fair (18 %), but was not formally assessed in four athletes (Table 2).
Serum levels of 25-hydroxyvitamin D (25(OH)D) as a function of skin colour among ninety-three Middle Eastern male athletes presenting to hospital for an annual screening, Doha, Qatar, April–October 2008
Serum 25(OH)D was not dependent on the reported skin colour (χ 2 = 3·40, NS).
Relationship between vitamin D status and other parameters
Our data showed that athletes with either deficiency (33 %) or severe deficiency (58 %) of 25(OH)D were significantly younger than the group with higher 25(OH)D concentrations (F 2,90 = 3.2, P < 0·05; Fig. 2). However, there were no significant differences in BMI between the three groups (F 2,88 = 1·5, NS; Fig. 2), nor were there any significant differences in the variables estimated by the questionnaire between the groups with different 25(OH)D status: typical skin exposure (χ 2 = 0·43, NS; Table 1), skin colour (χ 2 = 3·40, NS; Table 2), sunlight exposure (χ 2 = 3·77, NS). Furthermore, 25(OH)D status did not affect the Ca levels in the sample of athletes (F 2,90 = 1·1, NS; Fig. 2) but athletes with severe 25(OH)D deficiency displayed significantly higher PTH levels than the other groups (F 2,89 = 6·0, P < 0·05; Fig. 2). There was no effect of the level of 25(OH)D deficiency on BMD (all F 2,36 < 2·1, NS). The above results were unchanged when age was considered as a covariate. Our results suggested a prevalence of low BMD, with only sixteen of thirty-nine athletes (41 %) presenting with Z-scores higher than −1 and twenty-three of thirty-nine (59 %) having at least one Z-score below −1.
Relationship between serum levels of 25-hydroxyvitamin D (25(OH)D) and mean age, BMI, total Ca and parathyroid hormone (PTH) among ninety-three Middle Eastern male athletes presenting to hospital for an annual screening, Doha, Qatar, April–October 2008. Values are means with standard deviations represented by vertical bars. Mean values were significantly different between groups: *P < 0·05
Discussion
The major finding of the present study is that young, active Middle Eastern males have an extremely high prevalence of 25(OH)D deficiency. All of our sample of athletes had suboptimal 25(OH)D concentration, with 58 % having severe vitamin D deficiency and a further 32 % being deficient. The levels of deficiency observed are as high as or higher than those previously described in non-athletic groups of Middle Eastern men and women(Reference Hashemipour, Larijani and Adibi15, Reference Hatun, Islam and Cizmecioglu24, Reference Sedrani, Wahab and Elidrissy26, Reference Sedrani36).
1,25(OH)2D is an essential component of Ca and P metabolism, with low levels resulting in impaired Ca absorption, elevation of PTH and osteopenia(Reference Tang, Eslick and Nowson37, Reference Abrams, Grifin and Hawthorne38). Of note, in the present study we observed an inverse relationship between 25(OH)D concentration and PTH, but no relation with total Ca or BMD. While in many cases the exact mechanisms are yet to be elucidated, 25(OH)D is also recognized as being associated with chronic health conditions including diabetes and bowel cancer(Reference Holick5). It is interesting to note that these conditions are among the most pressing issues facing the health-care system in Qatar(Reference Chanpong39). While 25(OH)D deficiency has been well described in Middle Eastern women(Reference Allali, El Aichaoui and Saoud22–Reference Hatun, Islam and Cizmecioglu24), and increasingly is recognized as a worldwide phenomenon, there is a paucity of literature regarding the 25(OH)D status of Middle Eastern men(Reference Hashemipour, Larijani and Adibi15, Reference Siam, Hammoudeh and Bener25). The present study confirms that Middle Eastern men are also vulnerable to 25(OH)D deficiency.
Numerous factors including absolute sunlight exposure, insufficient dietary vitamin D, malabsorption of dietary vitamin D, UV light insulation due to atmospheric dust particles, altered vitamin D metabolism and the use of concealing clothing have all been postulated as factors involved in the prevalence of vitamin D deficiency in the Middle East(Reference Sedrani, Wahab and Elidrissy26, Reference Awumey, Mitra and Hollis40). We found no relationship between 25(OH)D concentration in men and training either in or out of doors, use of sunscreen, sunlight exposure or skin coverage. While the wearing of concealing clothing has been associated with vitamin D deficiency in Middle Eastern women(Reference Fonseca, Tongia and El-Hazmi23, Reference Hatun, Islam and Cizmecioglu24), our data show no such relationship between sunlight/skin exposure and 25(OH)D concentration. This lack of association has been noted previously in both Middle Eastern and northern hemisphere countries(Reference Hashemipour, Larijani and Adibi15, Reference Andersen, Molgaard and Skovgaard18). Even in adolescents with high levels of unprotected sunlight exposure, 25(OH)D concentrations have been found to be low(Reference Binkley, Novotny and Krueger14). In our sample, the majority exposed only limited amounts of skin (Table 1) and a third of the athletes described less than 30 min of daily sunlight exposure. While not formally assessed, it is our observation that as a result of heat and other social factors, most outdoor training is in fact performed after sunset, suggesting that actual effective UVB exposure may be low. Furthermore, we observed a non-significant trend for darker skin to be associated with a lower concentration of 25(OH)D. This reflects the photo-protective effect of skin pigmentation(Reference Matsuoka, Wortsman and Haddad41, Reference Clemens, Adams and Henderson42), and further supports the speculation that effective UVB exposure is the principal cause of the 25(OH)D deficiency in this cohort. Lack of a range of normal 25(OH)D levels may have contributed to this lack of association and hence the actual impact of exposure to sunlight on 25(OH)D concentration in this cohort requires further evaluation.
Of note, athletes with low 25(OH)D were significantly younger than those with higher levels. This finding is consistent with some authors(Reference Hashemipour, Larijani and Adibi15) but not others(Reference Sedrani36), and may reflect increased sunlight exposure with increasing age or altered vitamin D metabolism with increasing age. BMI and smoking have previously been shown to have a negative association with 25(OH)D concentration, but this was not illustrated in the current group of athletes(Reference Andersen, Molgaard and Skovgaard18). However, these trends need to be considered against the uniformly deficient 25(OH)D concentration in this cohort, restricting the likelihood of finding an association.
Given the reported relationship between 25(OH)D, BMD and bone stress injuries(Reference Hannan, Litman and Araujo17, Reference Lappe, Cullen and Haynatzki35), it is not surprising that 59 % of our sample was found to have low BMD (at least one Z-score below −1). Hannan et al.(Reference Hannan, Litman and Araujo17) reported significant ethnic differences on the impact of 25(OH)D concentration and BMD, with white men having a strong correlation between 25(OH)D concentration and BMD but no such relationship being present in black or Hispanic men. Our data showed that BMD and 25(OH)D were not statistically linked in a sample of Middle Eastern male athletes. It is possible that genetic polymorphism in the 25(OH)D/1,25(OH)2D pathway may potentially account for some of these differences, and this warrants further investigation(Reference Rabon-Stith, Hagberg and Phares43). However, it is interesting that in this cohort of athletes with low levels of 25(OH)D, inversely elevated PTH and low BMD, there were no reported stress fractures. This may be a result of a number of factors including the training intensity, age of subjects or other protective mechanisms within the cohort.
In the mid-20th century athletes were supposedly using UV light as a performance aid, although scientific evidence to support its use was limited(Reference Cannell, Hollis and Sorenson29–Reference Hoberman31). Severe 25(OH)D deficiency is known to be associated with reduced type II muscle fibre composition(Reference Glerup, Mikkelsen and Poulsen44–Reference Russell47) and the sarcopenia associated with ageing is thought to be affected by 25(OH)D concentrations(Reference Gerdhem, Ringsberg and Obrant48–Reference Visser, Deeg and Lips50). Recently, 25(OH)D deficiency was shown to be associated with reduced physical performance both in young and aged populations(Reference Ward, Das and Berry32, Reference Glerup, Mikkelsen and Poulsen44). Given the accumulating evidence from numerous sources implicating 1,25(OH)2D and its metabolic pathways in the optimal functioning of skeletal muscle, it is important that young athletes have appropriate 25(OH)D concentrations. This is not currently being achieved in this cohort. Safe and appropriate levels of sunlight exposure should be sufficient to provide adequate 25(OH)D concentrations in this cohort. However, the cultural practice of wearing concealing clothing, combined with intense heat that is not conducive to spending time in the sun, makes this difficult to achieve. Furthermore, as food is not currently fortified with dietary vitamin D in Qatar, the routine supplementation of athletes in the Middle East may be required. Given that the treatment of 25(OH)D deficiency has been shown to be both safe and efficacious, the inclusion of 25(OH)D assessments in athlete screening is warranted. Management of 25(OH)D deficiency should include education regarding appropriate sunlight exposure and either oral or intramuscular correction of deficiencies(Reference Holick1). In those athletes not screened for 25(OH)D deficiency, routine advice on appropriate sunlight exposure should be provided. However, the merits of routine supplementation in this cohort without 25(OH)D assessment are unclear. Unfortunately, in many regions 25(OH)D continues to be an expensive assessment and there continues to be concern about inter-laboratory variability, and as a result it is often not part of a routine assessment(Reference Binkley, Kreuger and Cowgill51).
Conclusions
The current trial suggests that 25(OH)D deficiency is endemic in Middle Eastern sportsmen. With such high rates of 25(OH)D deficiency in a young active population (91 %), longitudinal trials should be performed to assess the impact of this deficiency early in life on long-term health outcomes in an otherwise healthy and active cohort. Given the potential for both significant short- and long-term consequences of 25(OH)D deficiency, evaluation and management of 25(OH)D deficiency should be included as part of the routine assessment of athletes in this region of the world. Furthermore, treatment of this deficiency would appear critical if this group is not to be at elevated risk of chronic health issues in the future.
Acknowledgements
Sources of funding: Funding for this project was internal, with no external grants received. Conflict of interest declaration: The authors have no known conflict of interest. Author contributions: B.H. contributed to the concept, study design and development, results collation and evaluation, and manuscript preparation. J.G. contributed to the study design and implementation, data analysis, and manuscript preparation and review. S.R. contributed to the study design, data collation and statistical analysis, and manuscript review. H.C. had overall project responsibility, contributed to the study concept and preparation, data review and manuscript review, and made the decision regarding submission. Acknowledgements: The authors would like to acknowledge the work of Dr Cristiano Eirale, Dr Claude Tremblay, Dr Massimilliano Sala, Dr Jean-Claude Chatard and Dr Justin Paoloni in the collection of data, and the support of Nellie Khalil, Sirine Boukarroum and Paschal Tahtouh in data collection and collation.
